News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,720 Results
Type
Article (2633)
Company Profile (45)
Press Release (38041)
Multimedia
Podcasts (9)
Webinars (2)
Section
Business (14342)
Career Advice (80)
Deals (2132)
Drug Delivery (9)
Drug Development (4249)
Employer Resources (10)
FDA (454)
Job Trends (790)
News (20543)
Policy (1072)
Tag
Academia (149)
Allergies (7)
Alliances (3542)
ALS (6)
Alzheimer's disease (60)
Antibody-drug conjugate (ADC) (27)
Approvals (457)
Artificial intelligence (32)
Autoimmune disease (8)
Automation (2)
Bankruptcy (12)
Best Places to Work (485)
BIOSECURE Act (2)
Biosimilars (16)
Biotechnology (29)
Bladder cancer (8)
Brain cancer (7)
Breast cancer (44)
Cancer (325)
Cardiovascular disease (10)
Career advice (68)
Career pathing (1)
CAR-T (32)
CDC (1)
Cell therapy (86)
Cervical cancer (2)
Clinical research (3504)
Collaboration (202)
Company closure (2)
Compensation (104)
COVID-19 (188)
CRISPR (14)
C-suite (112)
Cystic fibrosis (7)
Data (430)
Denatured (6)
Depression (11)
Diabetes (17)
Diagnostics (494)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (36)
Drug pricing (10)
Duchenne muscular dystrophy (40)
Earnings (4557)
Editorial (5)
Employer branding (1)
Employer resources (8)
Events (6498)
Executive appointments (134)
FDA (601)
Friedreich's ataxia (4)
Frontotemporal dementia (1)
Funding (169)
Gene editing (40)
Generative AI (1)
Gene therapy (56)
GLP-1 (63)
Government (161)
Guidances (24)
Healthcare (713)
HIV (1)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (35)
Immuno-oncology (14)
Indications (4)
Infectious disease (200)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (25)
Interviews (7)
IPO (1013)
IRA (7)
Job creations (293)
Job search strategy (64)
JPM (4)
Kidney cancer (6)
Labor market (11)
Layoffs (51)
Leadership (3)
Legal (216)
Liver cancer (6)
Longevity (1)
Lung cancer (28)
Lymphoma (12)
Machine learning (3)
Management (4)
Manufacturing (53)
MASH (14)
Medical device (318)
Medtech (319)
Mergers & acquisitions (1237)
Metabolic disorders (72)
Multiple sclerosis (22)
Neurodegenerative disease (27)
Neuropsychiatric disorders (10)
Neuroscience (165)
NextGen: Class of 2026 (359)
Non-profit (158)
Now hiring (11)
Obesity (32)
Opinion (17)
Ovarian cancer (17)
Pain (24)
Pancreatic cancer (21)
Parkinson's disease (11)
Partnered (4)
Patents (53)
Patient recruitment (26)
Peanut (1)
People (5915)
Pharmaceutical (5)
Phase 1 (1515)
Phase 2 (1740)
Phase 3 (922)
Pipeline (396)
Policy (16)
Postmarket research (30)
Preclinical (674)
Press Release (2)
Prostate cancer (8)
Psychedelics (3)
Radiopharmaceuticals (14)
Rare diseases (65)
Real estate (429)
Recruiting (5)
Regulatory (930)
Reports (7)
Research institute (154)
Resumes & cover letters (9)
Rett syndrome (1)
RNA editing (5)
RSV (1)
Schizophrenia (16)
Series A (47)
Series B (21)
Service/supplier (2)
Sickle cell disease (5)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (499)
Stomach cancer (2)
Supply chain (4)
Tariffs (2)
The Weekly (3)
Vaccines (53)
Venture capital (16)
Weight loss (21)
Women's health (10)
Worklife (1)
Date
Last 7 days (40)
Last 30 days (148)
Last 365 days (2441)
2026 (213)
2025 (2468)
2024 (2647)
2023 (2899)
2022 (3814)
2021 (4120)
2020 (3529)
2019 (2100)
2018 (1574)
2017 (1830)
2016 (1635)
2015 (1859)
2014 (1400)
2013 (1213)
2012 (1420)
2011 (1354)
2010 (1193)
Location
Africa (44)
Alabama (3)
Arizona (19)
Asia (1992)
Australia (312)
California (1624)
Canada (243)
China (81)
Colorado (54)
Connecticut (16)
Delaware (5)
Europe (4082)
Florida (64)
Georgia (11)
Hawaii (2)
Idaho (3)
Illinois (21)
India (3)
Indiana (60)
Japan (20)
Kansas (14)
Kentucky (1)
Maryland (48)
Massachusetts (585)
Michigan (14)
Minnesota (23)
Mississippi (1)
Missouri (4)
Nebraska (2)
Nevada (3)
New Hampshire (4)
New Jersey (133)
New York (81)
North Carolina (132)
North Dakota (1)
Northern California (793)
Ohio (44)
Oklahoma (2)
Oregon (6)
Pennsylvania (109)
Puerto Rico (1)
Rhode Island (3)
South America (40)
South Carolina (1)
Southern California (658)
Tennessee (4)
Texas (153)
United States (3252)
Utah (5)
Virginia (11)
Washington D.C. (3)
Washington State (98)
West Virginia (1)
Wisconsin (13)
40,720 Results for "locus biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Locus Biosciences Enters Research Collaboration to Develop Precision Antibacterial Therapies for Ophthalmic Infections
October 29, 2025
·
2 min read
Press Releases
Locus Biosciences Awarded $3.3 Million from NIH to Support Clinical Trial of AI-Designed Bacteriophage Therapy for Pneumonia caused by Antibiotic Resistant Bacteria
January 8, 2026
·
3 min read
Gene editing
Regeneron Makes $275M Gene Editing Play With Tessera Partnership Targeting AATD
The centerpiece of the deal is the
in vivo
editor TSRA-196, which in preclinical studies has shown robust editing at SERPINA1, the locus linked to alpha-1 antitrypsin deficiency.
December 1, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Locus Cell’s Zhubei Smart GMP Facility Secures First International Phase III CDMO Manufacturing MOU with Cambium Bio
September 29, 2025
·
1 min read
Drug Development
Locus Biosciences Announces $23.9 Million in Funding from BARDA to Support First Phase 2 Trial of CRISPR-engineered Bacteriophage Therapy
Locus Biosciences, Inc. today announced the release of $23.9 million from the Biomedical Advanced Research and Development Authority (BARDA) to continue the development of Locus’ CRISPR-enhanced bacteriophage therapy, LBP-EC01, for treating urinary tract infections (UTIs) caused by drug-resistant Escherichia coli (E. coli) based on positive results from a Phase 2a clinical trial.
January 23, 2024
·
5 min read
Press Releases
Change in Number of Shares and Votes in Alligator Bioscience AB
February 1, 2026
·
1 min read
BioMidwest
Basking Biosciences Presents Novel Reversible RNA-aptamer Thrombolytic at Locus Walk RNA Innovation Conference
Basking Biosciences (Basking), a clinical-stage biopharmaceutical company, today discussed the development status of BB-031, the company’s novel, RNA-based thrombolytic for use in patients experiencing acute ischemic stroke, at the Locus Walk RNA Innovation Conference, held virtually.
May 9, 2023
·
4 min read
Press Releases
Imbed Biosciences Secures Strategic Investment from BioLab Holdings
February 4, 2026
·
2 min read
Press Releases
Invitation to Alligator Bioscience’s Earnings Call on 12 February 2026
February 5, 2026
·
1 min read
Press Releases
Genflow Biosciences PLC Announces Directorate Change
January 19, 2026
·
6 min read
1 of 4,072
Next
